Related Experiment Video
Updated: Jul 3, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Metabolic crisis and TRPM4 activation cause QT prolongation in TANGO2 deficiency disorder
Lili Wang1, Kyungsoo Kim1, Prince J Kannankeril2
1Vanderbilt Center for Arrhythmia Research and Therapeutics, Division of Clinical Pharmacology, Vanderbilt University Medical Center, 2215B Garland Ave, Nashville, TN 37232-0575, USA.
Aims:
TANGO2 deficiency disorder (TDD), caused by biallelic pathogenic variants in TANGO2, is associated with impaired fatty acid oxidation and metabolic crises that frequently trigger QT prolongation and arrhythmias. The objective was to study the mechanisms responsible for QT prolongation and arrhythmogenesis in TDD.
Methods And Results:
CRISPR/Cas9 were used to generate human-induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) carrying a TANGO2 exon 3-9 deletion (TANGO2-/-). Bioenergetic function (mitochondrial oxygen consumption rate, intracellular ATP/ADP ratio) and action potentials (APs) were studied under glucose- or palmitate-fueled conditions. This study reports a TDD clinical case of QT prolongation and arrhythmia that responded favourably to L-type calcium channel (LTCC) inhibition with verapamil or vitamin B-complex supplementation. The mechanisms underlying clinical presentations and therapeutic responses were investigated using TANGO2-/- hiPSC-CMs. In glucose-containing medium, the bioenergetic function was comparable between control and TANGO2-/- hiPSC-CMs. In contrast, using palmitate as energy substrate triggered a profound reduction in cellular ATP production rate and decreased ATP/ADP ratios in TANGO2-/- hiPSC-CMs, exacerbated by 24-h fasting. This crisis was prevented by 2-week treatment with vitamins B5 and B9. During the crisis, TANGO2-/- hiPSC-CMs exhibited AP prolongation, prevented by intracellular delivery of Mg-ATP or creatine kinase. LTCC inhibition with verapamil prevented AP prolongation by normalizing ATP/ADP ratios and intracellular Ca mishandling. Importantly, the metabolic crisis upregulated TRPM4, an ATP- and Ca-regulated channel. TRPM4 siRNA knockdown or pharmacological block prevented AP prolongation without rescuing the energetic deficit of TANGO2-/- hiPSC-CMs.
Conclusion:
These findings suggest a mechanistic link between ATP deficiency, TRPM4 activation, and AP prolongation in TDD. Targeting TRPM4 therapeutically may help prevent QT prolongation and cardiac arrhythmias in TDD crisis.
Insights
TANGO2 deficiency disorder causes cardiac issues due to impaired energy metabolism. TRPM4 channel activation, linked to ATP deficiency, drives action potential prolongation and arrhythmias in this condition.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- TANGO2 deficiency disorder (TDD) involves impaired fatty acid oxidation, leading to metabolic crises, QT prolongation, and arrhythmias.
- The precise mechanisms underlying these cardiac complications in TDD remain incompletely understood.
Purpose of the Study:
- To investigate the mechanisms responsible for QT prolongation and arrhythmogenesis in TANGO2 deficiency disorder.
- To explore potential therapeutic targets for TDD-associated cardiac dysfunction.
Main Methods:
- Generated TANGO2-deficient human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) using CRISPR/Cas9.
- Assessed bioenergetic function and action potentials under varying substrate conditions (glucose vs. palmitate).
- Investigated the role of L-type calcium channels (LTCCs) and TRPM4 channels in TDD cardiac phenotypes.
Main Results:
- TANGO2-/- hiPSC-CMs exhibited impaired ATP production and reduced ATP/ADP ratios when fueled by palmitate, mimicking metabolic crisis.
- Palmitate-induced crisis led to action potential prolongation, which was ameliorated by Mg-ATP, creatine kinase, or LTCC inhibition (verapamil).
- Metabolic crisis upregulated TRPM4 channels, and TRPM4 inhibition prevented action potential prolongation without restoring bioenergetics.
Conclusions:
- A mechanistic link exists between ATP deficiency, TRPM4 channel activation, and action potential prolongation in TDD.
- TRPM4 channel activation contributes significantly to the arrhythmogenic phenotype in TDD.
- Targeting TRPM4 presents a potential therapeutic strategy for preventing cardiac arrhythmias in TDD crises.
More Related Videos
07:35Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Inborn Errors of Metabolism
Type II Diabetes I: Introduction
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Dysrhythmias II: Classification of Tachyarrhythmias
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase